Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

Depolarizing Blockers: Mechanism of Action

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...

Salivary Glands and Saliva

Salivary Glands and Saliva

The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Need for Tympanostomy Tubes in Children With Recurrent Acute Otitis Media Without Middle Ear Effusion.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2023

Same author

Choosing Wisely Canada - pediatric otolaryngology recommendations.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2021

Same author

New Feeding Assessment Scale for individuals with genetic syndromes: Validity and reliability in the CHARGE syndrome population.

Journal of paediatrics and child health·2021

Same author

A case report and literature review: Factitious disorder imposed on another and malingering by proxy.

Paediatrics & child health·2020

Same author

Evaluating short and long term outcomes following pediatric Myringoplasty with Gelfoam graft for tympanic membrane perforation following ventilation tube insertion.

Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale·2019

Same author

Guidelines in CHARGE syndrome and the missing link: Cranial imaging.

American journal of medical genetics. Part C, Seminars in medical genetics·2017

Search research articles

Related Experiment Video

Updated: May 24, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Botulinum toxin injections into salivary glands to decrease oral secretions in CHARGE syndrome: prospective case

Kim D Blake¹, Jillian MacCuspie, Gerard Corsten

¹Department of Pediatrics, IWK Health Center, Halifax, Nova Scotia, Canada. kim.blake@dal.ca

American Journal of Medical Genetics. Part A

|March 16, 2012

Summary

This study shows Botulinum toxin A (Botox) can effectively reduce excess salivary secretions in infants with CHARGE syndrome, preventing aspiration and avoiding tracheotomy. This treatment offers a unique approach for managing this complex genetic disorder.

More Related Videos

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction

Published on: April 24, 2016

Retroductal Nanoparticle Injection to the Murine Submandibular Gland

Retroductal Nanoparticle Injection to the Murine Submandibular Gland

Published on: May 3, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction

Published on: April 24, 2016

Retroductal Nanoparticle Injection to the Murine Submandibular Gland

Retroductal Nanoparticle Injection to the Murine Submandibular Gland

Published on: May 3, 2018

Area of Science:

Genetics
Pediatrics
Otolaryngology

Background:

CHARGE syndrome is a complex genetic disorder linked to CHD7 gene mutations.
Key diagnostic features include ocular coloboma, choanal atresia, ear abnormalities, and cranial nerve issues.
Patients frequently experience dysphagia, increasing aspiration risk from gastrointestinal secretions.

Observation:

A ventilator-dependent infant with CHARGE syndrome presented with excessive salivary secretions.
The infant was at high risk for tracheotomy due to aspiration complications.
Botulinum toxin A (Botox) was administered to manage salivary hypersecretion.

Findings:

Intermittent and prospective use of Botox successfully reduced salivary secretions.
This intervention prevented aspiration-related complications in the infant.
Botox therapy obviated the need for a tracheotomy in this case.

Implications:

Botox offers a viable, non-surgical alternative for managing sialorrhea in infants with CHARGE syndrome.
This approach can prevent serious aspiration complications and improve patient outcomes.
Further research into Botox for managing secretions in CHARGE syndrome is warranted.